From July 1, 2022 to August 15, 2022, the company has repurchased 0 shares, representing 0% for CAD 0 million. With this, the company has completed the repurchase of 38,000 shares, representing 1.52% for CAD 14.78 million under the buyback announced on August 11, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
290 CAD | +1.75% | 0.00% | -6.45% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 04 | Biolinq Incorporated announced that it has received $58 million in funding from a group of investors | CI |
1st Jan change | Capi. | |
---|---|---|
-6.45% | 514M | |
-6.08% | 113B | |
+20.42% | 63.85B | |
+5.51% | 61.9B | |
+10.52% | 42.86B | |
+9.44% | 40.84B | |
+18.75% | 34.58B | |
+5.43% | 25.46B | |
-4.17% | 22.13B | |
+2.19% | 18.61B |
- Stock Market
- Equities
- SEC Stock
- News Senvest Capital Inc.
- Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2021.